INFI
Infinity Pharmaceuticals, Inc.
NasdaqGS
People also watch:AEGRIRWDSNTACLVSARRY
1.700.08 (4.94%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close1.62
Open1.60
Bid1.68 x 1100
Ask1.69 x 700
52wk Range1.24 - 10.85
Day's Range1.55 - 1.72
Volume686,739
Avg Vol (3m)1,454,777
As of 1:18 PM EDT. NasdaqGS Real Time Price. Market open.
  • Capital Cube11 days ago

    ETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Infinity Pharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to INFI-US. Comparing the performance and risk of Infinity Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016 appeared first on CapitalCube.

  • Zackslast month

    Infinity Regains Duvelisib Rights, Announces Restructuring

    Infinity Pharmaceuticals (INFI) regained rights to develop and commercialize duvelisib; the company plans to eliminate 100 positions across the organization.